LexAurum Advisors’s Merck MRK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $1.71M | Buy |
13,291
+86
| +0.7% | +$10.1K | 0.2% | 93 |
|
|
2026
Q1 | $1.59M | Buy |
+13,205
| New | +$1.52M | 0.21% | 93 |
|
|
2025
Q3 | $1.05M | Buy |
12,522
+1,001
| +9% | +$82.4K | 0.15% | 115 |
|
|
2025
Q2 | $912K | Buy |
11,521
+12
| +0.1% | +$954 | 0.14% | 126 |
|
|
2025
Q1 | $1.03M | Buy |
11,509
+9
| +0.1% | +$840 | 0.2% | 106 |
|
|
2024
Q4 | $1.14M | Buy |
11,500
+450
| +4% | +$46.4K | 0.23% | 91 |
|
|
2024
Q3 | $1.25M | Buy |
11,050
+62
| +0.6% | +$7.37K | 0.28% | 79 |
|
|
2024
Q2 | $1.36M | Sell |
10,988
-454
| -4% | -$58.5K | 0.33% | 63 |
|
|
2024
Q1 | $1.51M | Buy |
11,442
+41
| +0.4% | +$5.05K | 0.38% | 52 |
|
|
2023
Q4 | $1.24M | Sell |
11,401
-14
| -0.1% | -$1.45K | 0.33% | 67 |
|
|
2023
Q3 | $1.18M | Buy |
11,415
+604
| +6% | +$65.1K | 0.34% | 63 |
|
|
2023
Q2 | $1.25M | Buy |
10,811
+567
| +6% | +$64.4K | 0.38% | 56 |
|
|
2023
Q1 | $1.09M | Sell |
10,244
-57
| -0.6% | -$6.15K | 0.36% | 60 |
|
|
2022
Q4 | $1.14M | Sell |
10,301
-101
| -1% | -$10.3K | 0.41% | 47 |
|
|
2022
Q3 | $896K | Sell |
10,402
-2
| -0% | -$179 | 0.35% | 59 |
|
|
2022
Q2 | $949K | Buy |
10,404
+27
| +0.3% | +$2.39K | 0.35% | 58 |
|
|
2022
Q1 | $851K | Sell |
10,377
-1,544
| -13% | -$122K | 0.28% | 79 |
|
|
2021
Q4 | $914K | Buy |
11,921
+1,128
| +10% | +$89.8K | 0.3% | 65 |
|
|
2021
Q3 | $811K | Buy |
10,793
+78
| +0.7% | +$5.93K | 0.24% | 105 |
|
|
2021
Q2 | $833K | Buy |
10,715
+274
| +3% | +$20.4K | 0.25% | 102 |
|
|
2021
Q1 | $768K | Sell |
10,441
-16
| -0.2% | -$1.18K | 0.26% | 90 |
|
|
2020
Q4 | $816K | Sell |
10,457
-106
| -1% | -$8.11K | 0.29% | 83 |
|
|
2020
Q3 | $836K | Buy |
10,563
+299
| +3% | +$23.4K | 0.34% | 68 |
|
|
2020
Q2 | $757K | Sell |
10,264
-3
| -0% | -$226 | 0.41% | 59 |
|
|
2020
Q1 | $754K | Buy |
10,267
+2,813
| +38% | +$221K | 0.52% | 44 |
|
|
2019
Q4 | $647K | Buy |
7,454
+167
| +2% | +$13.7K | 0.32% | 78 |
|
|
2019
Q3 | $585K | Buy |
7,287
+304
| +4% | +$24.4K | 0.35% | 74 |
|
|
2019
Q2 | $559K | Hold |
6,983
| – | – | 0.35% | 71 |
|
|
2019
Q1 | $554K | Hold |
6,983
| – | – | 0.37% | 64 |
|
|
2018
Q4 | $509K | Buy |
6,983
+195
| +3% | +$13.8K | 0.39% | 60 |
|
|
2018
Q3 | $459K | Sell |
6,788
-314
| -4% | -$20K | 0.32% | 75 |
|
|
2018
Q2 | $411K | Buy |
7,102
+262
| +4% | +$14.8K | 0.36% | 74 |
|
|
2018
Q1 | $356K | Sell |
6,840
-314
| -4% | -$17K | 0.3% | 86 |
|
|
2017
Q4 | $400K | Buy |
+7,154
| New | +$397K | 0.37% | 82 |
|
Other funds holding MRK
ECSS
LexAurum Advisors's MRK Position: Q2 2026 in Review
LexAurum Advisors increased its Merck (MRK) stake by 0.65% in Q2 2026, buying an estimated $10.1K and bringing the position to 13,291 shares worth $1.71M. The position accounts for 0.2% of the portfolio, ranked #93.
LexAurum Advisors first reported a position in MRK in Q4 2017 and has held it in 34 quarters since. 1,867 funds tracked by Wall St. Rank hold MRK as of Q2 2026.
- LexAurum Advisors held 13,291 shares of Merck worth $1.71M as of Q2 2026.
- LexAurum Advisors bought 86 Merck shares in Q2 2026, an estimated $10.1K.
- Merck made up 0.2% of LexAurum Advisors's portfolio in Q2 2026, its #93 holding.
- LexAurum Advisors first reported a position in Merck in Q4 2017 and has held it in 34 quarters since.
- 1,867 funds tracked by Wall St. Rank held Merck as of Q2 2026.
Based on LexAurum Advisors's 13F filing for Q2 2026, filed 15 Jul 2026.